Upregulation of bcl-2 by the Epstein-Barr virus latent membrane protein LMP1: a B-cell-specific response that is delayed relative to NF-kappa B activation and to induction of cell surface markers.

An ability of the Epstein-Barr virus latent membrane protein LMP1 to enhance the survival of infected B cells through upregulation of the bcl-2 oncogene was first suggested by experiments involving gene transfection and the selection of stable LMP1+ clones (S. Henderson, M. Rowe, C. Gregory, F. Wang...

Celý popis

Podrobná bibliografie

Vydáno v:	J Virol
Hlavní autoři:	Rowe, M, Peng-Pilon, M, Huen, D S, Hardy, R, Croom-Carter, D, Lundgren, E, Rickinson, A B
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	American Society for Microbiology (ASM) 1994
Témata:	Research Article
On-line přístup:	https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC236961/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/7520093/ https://ncbi.nlm.nih.govhttps://doi.org/10.1128/jvi.68.9.5602-5612.1994
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!